The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

Ravindra Uppaluri, MD, PhD, discusses the background regarding locally advanced head and neck cancer and what the trial design of KEYNOTE-689 entailed.

The new project voted ahead by township officials Monday night is planned for roughly a block east, in the Merck campus on ...

Two healthcare Dow stocks stunned investors with their sharp falls in May. The worst-performing Dow stock last month plunged ...

During a Community Case Forum event, Adil Daud, MD, discussed immunotherapy options for cutaneous squamous cell carcinoma.

At the ongoing International Society for Stem Cell Research meeting, Chinese researchers reported they demonstrated that SPT6 homolog, histone chaperone and transcription elongation factor (SPT6) ...

Merck Animal Health receives EU CVMP positive opinion for Numelvi tablets for dogs: Rahway, New Jersey Saturday, June 14, 2025, 13:00 Hrs [IST] Merck Animal Health, known as MSD A ...

Cancer Biomarkers Market Advancement Cancer Biomarkers Market Research Report Information By Biomarker Type, By Cancer Type, By Profiling T ...

A former Harvard Medical School professor who claims he was fired for refusing to receive the Covid-19 vaccine was appointed ...

Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a ...

F ox News' Lisa Boothe is a self-professed fan of Bravo's "Real Housewives" franchise, but is she herself a wife? The controversial public figure is notoriously private about her ...

DelveInsight's, “Bladder Cancer Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 100+ ...